ARMC
AVDL

American Research & Management Company’s Avadel Pharmaceuticals AVDL Stock Holding History

American Research & Management Company’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$1K Hold
100
– – ﹤0.01% 388
2022
Q2 		$0 Hold
100
– – ﹤0.01% 395
2022
Q1 		$1K Hold
100
– – ﹤0.01% 382
2021
Q4 		$1K Hold
100
– – ﹤0.01% 370
2021
Q3 		$1K Hold
100
– – ﹤0.01% 363
2021
Q2 		$1K Hold
100
– – ﹤0.01% 366
2021
Q1 		$1K Hold
100
– – ﹤0.01% 350
2020
Q4 		$1K Hold
100
– – ﹤0.01% 363
2020
Q3 		$1K Buy
+100
New +$728 ﹤0.01% 333

Other funds holding AVDL

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
GJL
Gendell Jeffrey L $11.3B AUM 163.06% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $370M AUM 97.79% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
MWM
Modera Wealth Management Westwood, New Jersey $9.37B AUM 23.82% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

American Research & Management Company's AVDL Position: Q3 2022 in Review

American Research & Management Company held its Avadel Pharmaceuticals (AVDL) position steady in Q3 2022 at 100 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #388.

American Research & Management Company first reported a position in AVDL in Q3 2020 and has held it in 9 quarters since. 76 funds tracked by Wall St. Rank hold AVDL as of Q3 2022.

  • American Research & Management Company held 100 shares of Avadel Pharmaceuticals worth $1K as of Q3 2022.
  • American Research & Management Company left its Avadel Pharmaceuticals share count unchanged in Q3 2022.
  • Avadel Pharmaceuticals made up ﹤0.01% of American Research & Management Company's portfolio in Q3 2022, its #388 holding.
  • American Research & Management Company first reported a position in Avadel Pharmaceuticals in Q3 2020 and has held it in 9 quarters since.
  • 76 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q3 2022.

Based on American Research & Management Company's 13F filing for Q3 2022, filed 7 Oct 2022.